Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Cabergoline on Weight and Glucose Tolerance
This study has been completed.
Study NCT01395602   Information provided by Columbia University

First Received on July 14, 2011.   Last Updated on July 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Body Weight
Impaired Glucose Tolerance in Obese
Additional conditions recognized in this trial
Glucose Intolerance
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperglycemia
Metabolic Diseases
Signs and Symptoms
Interventions listed in this trial
Cabergoline
placebo
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antineoplastic Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Columbia University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services